Qiangling Sun

766 total citations
24 papers, 594 citations indexed

About

Qiangling Sun is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Qiangling Sun has authored 24 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Neurology. Recurrent topics in Qiangling Sun's work include Myasthenia Gravis and Thymoma (7 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (7 papers). Qiangling Sun is often cited by papers focused on Myasthenia Gravis and Thymoma (7 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (7 papers). Qiangling Sun collaborates with scholars based in China, Taiwan and Germany. Qiangling Sun's co-authors include Zhongliang Ma, Ping Wang, Yang Shao, Yanli Li, Wentao Fang, Yanping Hu, Caiyan Zhang, Xing Zhang, Ding Lei and Xiaomin Liu and has published in prestigious journals such as Oncogene, Frontiers in Immunology and Archives of Biochemistry and Biophysics.

In The Last Decade

Qiangling Sun

24 papers receiving 590 citations

Peers

Qiangling Sun

PRM

ONCOL

SURGE

Clementina Castro‐Hernández Mexico

Junyong Zhao China

Guobin Fu China

Jamsheed Javid Saudi Arabia

Deyao Xie China

Clifford C. Nwaeburu Germany

Lei Lü China

Qianqian Geng China

Clementina Castro‐Hernández Mexico

Qiangling Sun

483 ×1.0

364 ×1.0

70 ×1.4

PRM

52 ×1.1

ONCOL

32 ×0.8

SURGE

Citations per year, relative to Qiangling Sun Qiangling Sun (= 1×) peers Clementina Castro‐Hernández

Countries citing papers authored by Qiangling Sun

Since Specialization

Citations

This map shows the geographic impact of Qiangling Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiangling Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiangling Sun more than expected).

Fields of papers citing papers by Qiangling Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiangling Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiangling Sun. The network helps show where Qiangling Sun may publish in the future.

Co-authorship network of co-authors of Qiangling Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Qiangling Sun. A scholar is included among the top collaborators of Qiangling Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiangling Sun. Qiangling Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Yu, Zhitao Gu, Qiangling Sun, et al.. (2023). HNRNPA2B1 as a potential therapeutic target for thymic epithelial tumor recurrence: An integrative network analysis. Computers in Biology and Medicine. 155. 106665–106665. 5 indexed citations

Gu, Zhitao, et al.. (2022). miRNA-199a-5p/SLC2A1 axis regulates glucose metabolism in non-small cell lung cancer. Journal of Cancer. 13(7). 2352–2361. 23 indexed citations

Gu, Zhitao, Heng Zou, Hui Zhang, et al.. (2022). miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer. International Journal of Biological Sciences. 18(10). 4187–4202. 21 indexed citations

Sun, Qiangling, et al.. (2021). miR-224-5p-enriched exosomes promote tumorigenesis by directly targeting androgen receptor in non-small cell lung cancer. Molecular Therapy — Nucleic Acids. 23. 1217–1228. 52 indexed citations

Fang, Wentao, Chia-Hsin Wu, Qiangling Sun, et al.. (2021). Novel Tumor-Specific Antigens for Immunotherapy Identified From Multi-omics Profiling in Thymic Carcinomas. Frontiers in Immunology. 12. 748820–748820. 4 indexed citations

Li, Yanli, Hui Zhang, Jing Guo, et al.. (2021). Downregulation of LINC01296 suppresses non-small-cell lung cancer via targeting miR-143-3p/ATG2B. Acta Biochimica et Biophysica Sinica. 53(12). 1681–1690. 12 indexed citations

Qiu, Jinxin, Jingjing Zhang, Yanhui Ma, et al.. (2021). Tissue signals imprint Aiolos expression in ILC2s to modulate type 2 immunity. Mucosal Immunology. 14(6). 1306–1322. 23 indexed citations

Ku, Xin, Qiangling Sun, Lei Zhu, et al.. (2020). Deciphering tissue‐based proteome signatures revealed novel subtyping and prognostic markers for thymic epithelial tumors. Molecular Oncology. 14(4). 721–741. 9 indexed citations

Yang, Chenghao, et al.. (2020). The MiR-17-92 Gene Cluster is a Blood-Based Marker for Cancer Detection in Non-Small-Cell Lung Cancer. The American Journal of the Medical Sciences. 360(3). 248–260. 16 indexed citations

10.

Li, Jiadong, Ying Zhang, Xinju Zhang, et al.. (2020). Higher expression of miR-150-5p promotes tumorigenesis by suppressing LKB1 in non-small cell lung cancer. Pathology - Research and Practice. 216(11). 153145–153145. 14 indexed citations

11.

Lai, Liang‐Chuan, Qiangling Sun, Yuan Chen, et al.. (2019). Using proteomic profiling to characterize protein signatures of different thymoma subtypes. BMC Cancer. 19(1). 796–796. 5 indexed citations

12.

Qi, Pengfei, Yanli Li, Xiaomin Liu, et al.. (2019). Cryptotanshinone Suppresses Non-Small Cell Lung Cancer via microRNA-146a-5p/EGFR Axis. International Journal of Biological Sciences. 15(5). 1072–1079. 41 indexed citations

13.

Sun, Qiangling, et al.. (2018). Investigation of an optimal lysis method for the study of thymus and thymoma by mass spectrometry-based proteomics. Translational Cancer Research. 7(2). 391–400. 2 indexed citations

14.

Zhang, Caiyan, Huimin Wang, Xiaomin Liu, et al.. (2018). Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP. Oncogene. 38(11). 1892–1904. 69 indexed citations

15.

Sun, Qiangling, Xin Ku, Ning Xu, et al.. (2018). Investigation of an optimal lysis method for the study of thymus and thymoma by mass spectrometry-based proteomics. Translational Cancer Research. 7(2). 391–400. 4 indexed citations

16.

Sun, Qiangling, Wentao Fang, Jian Feng, et al.. (2012). Proteome analysis and tissue array for profiling protein markers associated with type B thymoma subclassification.. PubMed. 125(16). 2811–8. 3 indexed citations

17.

Sun, Qiangling, et al.. (2010). Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol. Journal of Cancer Research and Clinical Oncology. 137(3). 521–532. 44 indexed citations

18.

Sun, Qiangling, Xiaonan Kang, Yang Zhang, et al.. (2009). DSA affinity glycoproteome of human liver tissue. Archives of Biochemistry and Biophysics. 484(1). 24–29. 10 indexed citations

19.

Sun, Qiangling, Yinkun Liu, Wenjing Lü, et al.. (2007). Con A affinity glycoproteomics of normal human liver tissue. Science in China Series C Life Sciences. 50(3). 403–411. 4 indexed citations

20.

Zhou, Haijun, Yinkun Liu, Qiangling Sun, et al.. (2007). A glycoproteome database of normal human liver tissue. Journal of Cancer Research and Clinical Oncology. 133(6). 379–387. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact